Pharmacological basis and clinical evidence of dabigatran therapy

Dabigatran is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity. It has been approved in the European Union and the United States of America for the prevention of thrombosis after major orthopedic surgery. It has also been approved by the American Food and Drug Administ...

Descripción completa

Detalles Bibliográficos
Autores principales: Redondo, Santiago, Martínez, Maria-Paz, Ramajo, Marta, Navarro-Dorado, Jorge, Barez, Abelardo, Tejerina, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262761/
https://www.ncbi.nlm.nih.gov/pubmed/22189016
http://dx.doi.org/10.1186/1756-8722-4-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262761/
https://www.ncbi.nlm.nih.gov/pubmed/22189016
http://dx.doi.org/10.1186/1756-8722-4-53

Ejemplares similares